Overview of Pruritus Management in Patients With Chronic Liver Disease.
作者信息
Bonder Alan
机构信息
Associate Professor of Medicine Medical Director of Liver Transplant Division of Gastroenterology and Hepatology Beth Israel Deaconess Medical Center Harvard Medical School Boston, Massachusetts.
出版信息
Gastroenterol Hepatol (N Y). 2024 Aug;20(8):446-448.
Abstract
摘要
相似文献
1
Overview of Pruritus Management in Patients With Chronic Liver Disease.
Gastroenterol Hepatol (N Y). 2024 Aug;20(8):446-448.
2
Management of pruritus in chronic liver disease.
Dermatol Res Pract. 2015;2015:295891. doi: 10.1155/2015/295891. Epub 2015 Mar 10.
3
Prevalence of pruritus in patients with chronic liver disease: A multicenter study.
Hepatol Res. 2018 Feb;48(3):E252-E262. doi: 10.1111/hepr.12978. Epub 2017 Oct 10.
4
Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis.
BMC Gastroenterol. 2019 Oct 24;19(1):169. doi: 10.1186/s12876-019-1092-z.
5
How to define chronic pruritus: Symptom or disease?
Exp Dermatol. 2019 Dec;28(12):1461-1465. doi: 10.1111/exd.13953. Epub 2019 Jun 11.
6
The Correlation Between the Autotaxin Enzyme and Pruritus in Egyptian Patients Suffering from Chronic Liver Disease.
Antiinflamm Antiallergy Agents Med Chem. 2021;20(3):302-307. doi: 10.2174/1871523020666210114092924.
7
Recent advances in the management of pruritus in chronic liver diseases.
World J Gastroenterol. 2017 May 21;23(19):3418-3426. doi: 10.3748/wjg.v23.i19.3418.
8
Validity and Reliability of Persian Version of 12-Item Pruritus Severity Score Questionnaire in Patients with Chronic Liver Disease and Pruritus.
Middle East J Dig Dis. 2020 Oct;12(4):278-283. doi: 10.34172/mejdd.2020.194.
9
Pruritus of chronic cholestasis.
QJM. 1995 Sep;88(9):603-7.
10
Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses.
PLoS One. 2017 Jun 12;12(6):e0178991. doi: 10.1371/journal.pone.0178991. eCollection 2017.
本文引用的文献
1
Managing pruritus in chronic liver disease: An in-depth narrative review.
Clin Liver Dis (Hoboken). 2024 Jun 12;23(1):e0187. doi: 10.1097/CLD.0000000000000187. eCollection 2024 Jan-Jun.
2
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.
N Engl J Med. 2024 Feb 29;390(9):783-794. doi: 10.1056/NEJMoa2312100. Epub 2024 Feb 21.
3
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
N Engl J Med. 2024 Feb 29;390(9):795-805. doi: 10.1056/NEJMoa2306185. Epub 2023 Nov 13.
4
Systematic review: efficacy of therapies for cholestatic pruritus.
Therap Adv Gastroenterol. 2023 May 25;16:17562848231172829. doi: 10.1177/17562848231172829. eCollection 2023.
5
Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review.
Dig Dis Sci. 2023 Jun;68(6):2710-2730. doi: 10.1007/s10620-023-07862-z. Epub 2023 Mar 18.
6
Pharmacological Therapy of Pruritus in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
J Clin Gastroenterol. 2023 Feb 1;57(2):143-152. doi: 10.1097/MCG.0000000000001797.
7
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA.
J Hepatol. 2021 Jun;74(6):1344-1354. doi: 10.1016/j.jhep.2021.01.013. Epub 2021 Jan 21.
Zotero 插件